INDUCTION OF THE LYTIC VIRAL CYCLE IN EPSTEIN-BARR-VIRUS CARRYING BURKITT-LYMPHOMA LINES IS ACCOMPANIED BY INCREASED EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES

被引:14
作者
DIRENZO, L [1 ]
AVILACARINO, J [1 ]
KLEIN, E [1 ]
机构
[1] KAROLINSKA INST,DEPT TUMOR BIOL,S-10401 STOCKHOLM,SWEDEN
关键词
EPSTEIN BARR VIRUS; LYTIC CYCLE; MAJOR HISTOCOMPATIBILITY COMPLEX EXPRESSION;
D O I
10.1016/0165-2478(93)90008-P
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Six Epstein Barr virus (EBV) genome-carrying Burkitt lymphoma (BL) cultures (P3HR-1, Raji, Akata, Daudi, Rael and Jijoye) were induced to enter the lytic cycle. Phorbol esther (TPA), n-butyrate, 5-azacytidine (5AzaC) or anti-IgG were used according to their known inducing capacity on these cell lines. Concomitantly with the appearance of the viral early antigens (EA) in a proportion of cells, the expression of major histocompatibility complex (MHC) class II antigens increased in the cultures. On P3HR-1 and Raji cells class I expression also increased. The enhancement of MHC expression correlated with the efficiency of induction and required only an early event of the viral lytic cycle. Treatment of 3 EBV-negative lymphoma lines (BJAB, Ramos and BL41) with TPA plus n-butyrate or 5AzaC did not influence MHC expression. Moreover, BL lines which carry the EBV genome after having been infected in vitro and which cannot be induced for the viral lytic cycle did not change MHC expression after treatment with theinducing agents. In mixed cultures the allo-stimulatory capacity of induced cells with elevated MHC expression was stronger compared to the untreated ones.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 27 条
[1]   IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE [J].
ANDERSSON, M ;
PAABO, S ;
NILSSON, T ;
PETERSON, PA .
CELL, 1985, 43 (01) :215-222
[2]   T-CELL-MEDIATED INHIBITION OF EBV-INDUCED B-CELL TRANSFORMATION - RECOGNITION OF VIRUS-PARTICLES [J].
BEJARANO, MT ;
MASUCCI, MG ;
KLEIN, G ;
KLEIN, E .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) :359-364
[3]   TUMORIGENICITY OF CELLS TRANSFORMED BY ADENOVIRUS-TYPE-12 BY EVASION OF T-CELL IMMUNITY [J].
BERNARDS, R ;
SCHRIER, PI ;
HOUWELING, A ;
BOS, JL ;
VANDEREB, AJ ;
ZIJLSTRA, M ;
MELIEF, CJM .
NATURE, 1983, 305 (5937) :776-779
[4]   INCREASED SENSITIVITY OF HUMAN LYMPHOID LINES TO NATURAL-KILLER CELLS AFTER INDUCTION OF THE EPSTEIN-BARR VIRAL CYCLE BY SUPER-INFECTION OR SODIUM-BUTYRATE [J].
BLAZAR, B ;
PATARROYO, M ;
KLEIN, E ;
KLEIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (03) :614-627
[5]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[6]   EXPRESSION OF HISTOCOMPATIBILITY ANTIGEN-H-2K, ANTIGEN-D, AND ANTIGEN-L IS REDUCED IN ADENOVIRUS-12-TRANSFORMED MOUSE CELLS AND IS RESTORED BY INTERFERON-GAMMA [J].
EAGER, KB ;
WILLIAMS, J ;
BREIDING, D ;
PAN, S ;
KNOWLES, B ;
APPELL, E ;
RICCIARDI, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (16) :5525-5529
[7]  
EPSTEIN MA, 1966, J NATL CANCER I, V37, P547
[8]  
FRESEN KO, 1976, INT J CANCER, V17, P167
[9]   EPSTEIN-BARR VIRUS-INFECTIONS IN MALES WITH THE X-LINKED LYMPHOPROLIFERATIVE SYNDROME [J].
GRIERSON, H ;
PURTILO, DT .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (04) :538-545
[10]   EPSTEIN-BARR VIRUS (EBV) INDUCED POLYCLONAL AND MONOCLONAL B-CELL LYMPHOPROLIFERATIVE DISEASES OCCURRING AFTER RENAL-TRANSPLANTATION - CLINICAL, PATHOLOGIC, AND VIROLOGIC FINDINGS AND IMPLICATIONS FOR THERAPY [J].
HANTO, DW ;
GAJLPECZALSKA, KJ ;
FRIZZERA, G ;
ARTHUR, DC ;
BALFOUR, HH ;
MCCLAIN, K ;
SIMMONS, RL ;
NAJARIAN, JS .
ANNALS OF SURGERY, 1983, 198 (03) :356-369